NY State Senate Bill S8708A

Archive: Last Bill Status - Passed Senate

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed/Vetoed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (9)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
May 25, 2022	referred to health delivered to assembly passed senate
May 11, 2022	advanced to third reading
May 10, 2022	2nd report cal.
May 09, 2022	1st report cal.1097
May 03, 2022	print number 8708a
May 03, 2022	amend (t) and recommit to alcoholism and substance abuse
Apr 01, 2022	referred to alcoholism and substance abuse

Votes

view votes

May 25, 2022 - floor Vote

S8708A

floor

Aye

Nay

Absent

Excused

Abstained

May 9, 2022 - Alcoholism and Substance Use Disorders committee Vote

S8708A

committee

Aye

Nay

Aye with Reservations

Absent

Excused

Abstained

show Alcoholism and Substance Use Disorders committee vote details

Alcoholism and Substance Use Disorders Committee Vote: May 9, 2022

aye (4)

aye wr (2)

excused (1)

Brouk

Bill Amendments

Original

A (Active)

Original

A (Active)

S8708 - Details

See Assembly Version of this Bill:: A9324
Current Committee:: Assembly Health
Law Section:: Public Health Law
Laws Affected:: Amd §3309, Pub Health L
Versions Introduced in 2023-2024 Legislative Session:: S3112, A1588

S8708 - Summary

Requires public entities to maintain a stock of opioid antagonists to be adequate to ensure ready and appropriate access for use during emergencies.

S8708 - Sponsor Memo

 
BILL NUMBER: S8708

SPONSOR: MANNION
 
TITLE OF BILL:

An act to amend the public health law, in relation to requiring public
entities to carry opioid antagonists and requires training for staff in
the administration of opioid antagonists

 
TITLE OF BILL:

An act to amend the public health law, in relation to requiring public
entities to carry opioid antagonists and requires training for staff in
the administration of opioid antagonists

 
PURPOSE OR GENERAL IDEA OF BILL:

This bill requires all public facilities to carry opioid antagonists in
first aid kits and requires the education and training of staff persons
employed in such places in the administration of opioid antagonists,
which will allow for deaths due to overdoses to be prevented.

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 of the bill amends Section of the Public Health Law by...  The
new subdivisions require a supply of on-site opioid antagonists in
public facilities and having staff members to be trained and educated.

Section 2 provides the effective date.

 
JUSTIFICATION:

In November of 2019, a young woman named Erin lost her life in Roches-
ter, NY to an accidental Fentanyl overdose. Her relapse after months of
sobriety took her life. Like so many individuals that have fallen victim
to substance use disorder, her life had great meaning and immense worth.
Addiction is a disease that plagues 21 million Americans, and yet only
10% of them receive treatment. This disease is rapidly growing, and more
lives are being lost. Erin lost her life in a public space, and if
Narcan had been readily available and administered to her, her life
could have been saved. Action must be taken to avoid the loss of more
lives, which is the goal of this legislation. By making opioid antag-
onists available in first aid kits, more lives can potentially be saved.

The current opioid epidemic is the deadliest drug crisis in American
history, which has reached critical levels in New York State.  "Families
Against Fentanyl," an opioid awareness organization, analyzed data from
U.S. government sources in 2020 and 2021 and found that fentanyl over-
doses are now the leading cause of death for Americans aged between 18
and 45. In 2021, The Center for Disease Control and Prevention also
found that 175 people die every day in the United States due to over-
doses, many of which could have been prevented with proper training and
education of how to administer Narcan or naloxone. With thousands of New
Yorkers dying at the hands of this epidemic, it is essential that public
facilities across the state be required to carry, and have personnel
trained in the proper education and administration of, these lifesaving
drugs. Opioid antagonists like naloxone allow for trained administrators
to reverse an overdose on the spot. Research shows that public overdoses
make up a large percentage of the overdose cases statewide. Unfortunate-
ly, access to naloxone is still extremely limited, and establishments
that might be able to offer lifesaving administration of an opioid
antagonist are not required to have these drugs on site. As the state
Department of Health and various agencies take steps towards combating
the issue, it is crucial to strengthen protection measures for our
people. With an increased distribution and education of Narcan, more
lives can potentially be saved. Maintaining on-site opioid antagonists
in public places and equipping staff with the knowledge of administering
these life-saving medications are common sense solutions to potentially
preventing more fatalities. Fatal opioid overdose deaths are preventa-
ble. The keys to lowering the deat h toll are education, which helps to
fight the crippling stigma associated with the disease of addiction,
along with increased availability or distribution of opioid antagonists.
Having Narcan in first aid kits will allow for better access, and thus
more potential for saving lives. We must act now to prevent more deadly
overdoses.

Opioid antagonists, such as naloxone/Narcan or any other similarly
acting drug approved by the United States Food and Drug Administration,
have proven to be effective in the treatment of an opioid overdose.
Specifically, naloxone is an opioid blocker/receptor, which counteracts
life-threatening opioid overdoses by reversing the depression of the
central nervous system and respiratory system; thus, allowing an over-
dose victim's breathing to be restored. Naloxone is a non-addictive
medication that has no effect if opioids are absent. This ensures that
administration of naloxone has no potential for abuse and is safe for
administration by a person who is educated and trained for moments of
crisis.

This legislation requires all public facilities to carry opioid antag-
onists in first aid kits and requires the education and training of
staff persons employed in such places in the administration of opioid
antagonists and that at least two provisions of such opioid antagonist
be on site at all times: ambulances or first response service providers,
all public elementary and secondary schools, all non-public elementary
and secondary schools, charter schools, universities, school districts
or boards of education, restaurants, bars, construction sites,
libraries, grocery stores, banks, children's overnight camps, government
offices, after-school programs, community centers, publicly and private-
ly operated shelters, correctional facilities, county jails, police
stations, fire stations, pharmacies and doctors' offices, and others.
This legislation sets forth a definition of opioid antagonist to mean
any drug approved by the Food and Drug Administration that, when admin-
istered, negates or neutralizes the pharmacological effects of an opioid
in the body.

 
PRIOR LEGISLATIVE HISTORY:

 
FISCAL IMPLICATIONS:

To be determined.

 
EFFECTIVE DATE:
This act shall take effect immediately.

S8708 - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8708
 
                             I N  S E N A T E
 
                               April 1, 2022
                                ___________
 
 Introduced  by  Sen. MANNION -- read twice and ordered printed, and when
   printed to be committed to the Committee on Alcoholism  and  Substance
   Abuse
 
 AN  ACT  to amend the public health law, in relation to requiring public
   entities to carry opioid antagonists and requires training  for  staff
   in the administration of opioid antagonists

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Short title. This act shall be known and may  be  cited  as
 "Erin's law".
   §  2.  Subparagraph  (v)  of paragraph (a) of subdivision 3 of section
 3309 of the public health law, as added by chapter 148 of  the  laws  of
 2020, is amended and a new subdivision 8 is added to read as follows:
   (v) As used in this section, "entity" OR "PUBLIC ENTITY" includes, but
 is  not  limited to, a school district, public library, board of cooper-
 ative educational services, county vocational  education  and  extension
 board,  charter  school,  non-public  elementary  or  secondary  school,
 restaurant, bar,  retail  store,  shopping  mall,  barber  shop,  beauty
 parlor, theater, sporting or event center, inn, hotel or motel.
   8.  THE  COMMISSIONER SHALL REQUIRE ALL PUBLIC ENTITIES TO PROVIDE AND
 MAINTAIN ON-SITE OPIOID ANTAGONISTS, IN QUANTITIES AND TYPES  DEEMED  BY
 THE  COMMISSIONER, TO BE ADEQUATE TO ENSURE READY AND APPROPRIATE ACCESS
 FOR USE DURING EMERGENCIES TO ANY INDIVIDUAL ON  THE  PREMISES  OF  SUCH
 PUBLIC  ENTITY  SUSPECTED  OF  HAVING  AN OPIOID OVERDOSE WHETHER OR NOT
 THERE IS A PREVIOUS HISTORY OF  OPIOID  ABUSE  AT  SUCH  PUBLIC  ENTITY.
 PUBLIC  ENTITIES  SHALL  REQUIRE  AT LEAST TWO STAFF MEMBERS EMPLOYED BY
 SUCH PUBLIC ENTITY BE TRAINED IN THE  ADMINISTRATION  OF  OPIOID  ANTAG-
 ONISTS BY A PROGRAM APPROVED UNDER THIS SECTION.
   § 3. This act shall take effect immediately.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD14558-01-2

Co-Sponsors

S8708A (ACTIVE) - Details

See Assembly Version of this Bill:: A9324
Current Committee:: Assembly Health
Law Section:: Public Health Law
Laws Affected:: Amd §3309, Pub Health L
Versions Introduced in 2023-2024 Legislative Session:: S3112, A1588

S8708A (ACTIVE) - Summary

Requires public entities to maintain a stock of opioid antagonists to be adequate to ensure ready and appropriate access for use during emergencies.

S8708A (ACTIVE) - Sponsor Memo

 
BILL NUMBER: S8708A

SPONSOR: MANNION
 
TITLE OF BILL:

An act to amend the public health law, in relation to requiring public
entities to maintain a stock of opioid antagonists

 
PURPOSE OR GENERAL IDEA OF BILL:

This bill requires all public facilities to carry opioid antagonists in
first aid kits and requires the education and training of staff persons
employed in such places in the administration of opioid antagonists,
which will allow for deaths due to overdoses to be prevented.

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 of the bill amends Section of the Public Health Law by adding
the new subdivisions to require a supply of on-site opioid antagonists
in public facilities and the commissioner shall deem the quantity and
process.

Section 2 provides the effective date.

 
JUSTIFICATION:

In November of 2019, a young woman named Erin lost her life in Roches-
ter, NY to an accidental Fentanyl overdose. Her relapse after months of
sobriety took her life. Like so many individuals that have fallen victim
to substance use disorder, her life had great meaning and immense worth.
Addiction is a disease that plagues 21 million Americans, and yet only
10% of them receive treatment. This disease is rapidly growing, and more
lives are being lost. Erin lost her life in a public space, and if
Narcan had been readily available and administered to her, her life
could have been saved. Action must be taken to avoid the loss of more
lives, which is the goal of this legislation. By making opioid antag-
onists available in first aid kits, more lives can potentially be saved.

The current opioid epidemic is the deadliest drug crisis in American
history, which has reached critical levels in New York State.  "Families
Against Fentanyl," an opioid awareness organization, analyzed data from
U.S. government sources in 2020 and 2021 and found that fentanyl over-
doses are now the leading cause of death for Americans aged between 18
and 45. In 2021, The Center for Disease Control and Prevention also
found that 175 people die every day in the United States due to over-
doses, many of which could have been prevented with proper training and
education of how to administer Narcan or naloxone.  With thousands of
New Yorkers dying at the hands of this epidemic, it is essential that
public facilities across the state be required to carry, and have
personnel trained in the proper education and administration of, these
lifesaving drugs. Opioid antagonists like naloxone allow for trained
administrators to reverse an overdose on the spot. Research shows that
public overdoses make up a large percentage of the overdose cases state-
wide. Unfortunately, access to naloxone is still extremely limited, and
establishments that might be able to offer lifesaving administration of
an opioid antagonist are not required to have these drugs on site. As
the state Department of Health and various agencies take steps towards
combating the issue, it is crucial to strengthen protection measures for
our people. With an increased distribution and education of Narcan, more
lives can potentially be saved. Maintaining on-site opioid antagonists
in public places and equipping staff with the knowledge of administering
these life-saving medications are common sense solutions to potentially
preventing more fatalities. Fatal opioid overdose deaths are preventa-
ble. The keys to lowering the death toll are education, which helps to
fight the crippling stigma associated with the disease of addiction,
along with increased availability or distribution of opioid antagonists.
Having Narcan in first aid kits will allow for better access, and thus
more potential for saving lives. We must act now to prevent more deadly
overdoses.

Opioid antagonists, such as naloxone/Narcan or any other similarly
acting drug approved by the United States Food and Drug Administration,
have proven to be effective in the treatment of an opioid overdose.
Specifically, naloxone is an opioid blocker/receptor, which counteracts
life-threatening opioid overdoses by reversing the depression of the
central nervous system and respiratory system; thus, allowing an over-
dose victim's breathing to be restored. Naloxone is a non-addictive
medication that has no effect if opioids are absent. This ensures that
administration of naloxone has no potential for abuse and is safe for
administration by a person who is educated and trained for moments of
crisis.

This legislation requires all public facilities to carry opioid antag-
onists in first aid kits and requires the education and training of
staff persons employed in such places in the administration of opioid
antagonists and that at least two provisions of such opioid antagonist
be on site at all times: ambulances or first response service providers,
all public elementary and secondary schools, all non-public elementary
and secondary schools, charter schools, universities, school districts
or boards of education, restaurants, bars, construction sites,
libraries, grocery stores, banks, children's overnight camps, government
offices, after-school programs, community centers, publicly and private-
ly operated shelters, correctional facilities, county jails, police
stations, fire stations, pharmacies and doctors' offices, and others.
This legislation sets forth a definition of opioid antagonist to mean
any drug approved by the Food and Drug Administration that, when admin-
istered, negates or neutralizes the pharmacological effects of an opioid
in the body.

 
FISCAL IMPLICATIONS:

To be determined.

 
EFFECTIVE DATE:
This act shall take effect immediately.

S8708A (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  8708--A
 
                             I N  S E N A T E
 
                               April 1, 2022
                                ___________
 
 Introduced  by  Sen. MANNION -- read twice and ordered printed, and when
   printed to be committed to the Committee on Alcoholism  and  Substance
   Abuse  --  committee  discharged,  bill  amended, ordered reprinted as
   amended and recommitted to said committee
 
 AN ACT to amend the public health law, in relation to  requiring  public
   entities to maintain a stock of opioid antagonists

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Short title. This act shall be known and may  be  cited  as
 "Erin's law".
   §  2.  Subparagraph  (v)  of paragraph (a) of subdivision 3 of section
 3309 of the public health law, as added by chapter 148 of  the  laws  of
 2020, is amended and a new subdivision 8 is added to read as follows:
   (v) As used in this section, "entity" OR "PUBLIC ENTITY" includes, but
 is  not  limited to, a school district, public library, board of cooper-
 ative educational services, county vocational  education  and  extension
 board,  charter  school,  non-public  elementary  or  secondary  school,
 restaurant, bar,  retail  store,  shopping  mall,  barber  shop,  beauty
 parlor, theater, sporting or event center, inn, hotel or motel.
   8.  THE  COMMISSIONER  SHALL  REQUIRE  ALL PUBLIC ENTITIES TO MAINTAIN
 ON-SITE OPIOID ANTAGONISTS,  IN  QUANTITIES  AND  TYPES  DEEMED  BY  THE
 COMMISSIONER,  TO BE ADEQUATE TO ENSURE READY AND APPROPRIATE ACCESS FOR
 USE DURING EMERGENCIES TO ANY INDIVIDUAL ON THE PREMISES OF SUCH  PUBLIC
 ENTITY  SUSPECTED OF HAVING AN OPIOID OVERDOSE WHETHER OR NOT THERE IS A
 PREVIOUS HISTORY OF OPIOID ABUSE AT SUCH PUBLIC ENTITY.  THE COMMISSION-
 ER SHALL ESTABLISH A PROCESS BY  WHICH  PUBLIC  ENTITIES  MAY  APPLY  TO
 RECEIVE  OPIOID  ANTAGONISTS FREE OF CHARGE. SUCH PROCESS SHALL BE OPER-
 ATED IN COMPLIANCE WITH EXISTING LAWS, RULES, AND  REGULATIONS  RELATING
 TO THE DISTRIBUTION OF AN OPIOID ANTAGONIST.
   § 3. This act shall take effect immediately.
 

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD14558-02-2

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S8708A

Sponsored By

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

May 25, 2022 - floor Vote

Floor Vote: May 25, 2022

May 9, 2022 - Alcoholism and Substance Use Disorders committee Vote

Alcoholism and Substance Use Disorders Committee Vote: May 9, 2022

Bill Amendments

S8708 - Details

S8708 - Summary

S8708 - Sponsor Memo

S8708 - Bill Text download pdf

Co-Sponsors

S8708A (ACTIVE) - Details

S8708A (ACTIVE) - Summary

S8708A (ACTIVE) - Sponsor Memo

S8708A (ACTIVE) - Bill Text download pdf

Comments

senate Bill S8708A

Share this bill

Sponsored By

John W. Mannion

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

May 25, 2022 - floor Vote

Floor Vote: May 25, 2022

May 9, 2022 - Alcoholism and Substance Use Disorders committee Vote

Alcoholism and Substance Use Disorders Committee Vote: May 9, 2022

Bill Amendments

S8708 - Details

S8708 - Summary

S8708 - Sponsor Memo

S8708 - Bill Text download pdf

Co-Sponsors

Anna M. Kaplan

S8708A (ACTIVE) - Details

S8708A (ACTIVE) - Summary

S8708A (ACTIVE) - Sponsor Memo

S8708A (ACTIVE) - Bill Text download pdf

Comments